Unlike traditional growth hormone therapy, AOD-9604 does not significantly increase growth hormone or IGF-1 levels
Other drugs used to relieve pain, nausea, and vomiting, as well as anesthetics, can be administered subcutaneously
symptoms may include a mass in the neck, dysphagia, dyspnea or persistent hoarseness)
Projections indicate this market will reach around USD 1.3 billion in 2025, expanding to USD 2.292.6 billion by the early 2030s
Anecdotally, a few people will report noticeable effects from intranasal BPC-157 use such as a better mood, enhanced focus and deeper sleep
But a spokesman for the service said this included both prescribed medicines and unregulated peptides, as well as cases where people have been confused about dosing